Abstracts are required for all oral presentations, e-posters and paper posters
These are due to be submitted by October 1st, 2023, 23:59 CET., in English.
There is a limit of 2 oral communications and 2 posters per author.
Accepted abstracts will be published on the conference website and also in the congress Book of Abstracts. By submitting an abstract you consent to giving congress organization permission to publish your abstract.
In order to proceed with the withdraw of an abstract submission the congress secretariat must be notified in writing (congress@eventqualia.net) and you will receive a confirmation in response. Please, note that this will only be possible until 14 days after notification of acceptance.
The presenting author must register as "Author - Full conference" at the latest 14 days after acceptance of the abstract.
Failure to register shall not be regarded as an automatic withdrawal of your abstract. Withdrawal of an abstract can only be made by writing to the Secretariat (check the previous point).
Organization committee reserves the right to exclude any abstract from the scientific program that is not followed by a participant registration.
Please note that max. 2 oral presentations and max. 2 poster presentations by the same presenting author will be accepted for presentation at the conference. The presenting author does not have to be the 1st author.
The abstract word limit is max. 250 words per abstract excl. title, authors and affiliations. The congress secretariat reserves the right to edit abstracts that exceed the word limit
The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.
No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.
All abbreviations must be defined in first use. Statements such as “results will be discussed” or “data will be presented” cannot be accepted.
Use of brand names: For all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. Organization committee reserves the right to replace any brand name with a generic name without further notice.
Abstracts will not be accepted if previously presented at a congress conference unless there is a substantial increase in data.
The abstract must include the following:
The Scientific Committee will review the abstract
Notification of acceptance or rejection of the abstract will be sent to the submitter until October 7th, 2023.
It is the responsibility of all submitters that all studies are performed with respect to national legislation, international legislation and ethical guidelines both with regards to humans and animals. The Scientific Committee reserves the right to reject any submitted abstract that is believed to violate these principles.
Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
powered by eventQualia